Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
2021年11月12日 - 9:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of November 2021
Commission File Number: 001-37452
CELYAD ONCOLOGY SA
(Translation of registrants name into English)
Rue Edouard
Belin 2
1435 Mont-Saint-Guibert, Belgium
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Celyad Oncology SA
On November 12, 2021, Celyad Oncology SA (the Company) issued a press release, a copy of which is attached hereto as Exhibit 99.1
and is incorporated by reference herein.
The information contained in this Current Report on Form 6-K,
including Exhibit 99.1, except for the quotes of David Gilham and Charles Morris contained in Exhibit 99.1, is hereby incorporated by reference into the Companys Registration Statements on Form F-3 (File
No. 333-248464) and Form S-8 (File No. 333-220737).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
CELYAD ONCOLOGY SA
|
|
|
|
|
Date: November 12, 2021
|
|
|
|
By:
|
|
/s/ Filippo Petti
|
|
|
|
|
|
|
Filippo Petti
|
|
|
|
|
|
|
Chief Executive Officer and Financial Officer
|
Celyad (CE) (USOTC:CLYYF)
過去 株価チャート
から 9 2024 まで 10 2024
Celyad (CE) (USOTC:CLYYF)
過去 株価チャート
から 10 2023 まで 10 2024
Real-Time news about Celyad SA (CE) (その他OTC): 0 recent articles
その他のCelyad Oncology Saニュース記事